Skip to contentpdufa.bio

oral COVID-19

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

oral COVID-19 is a Vaxart, Inc. program in COVID-19 prevention. Its next catalyst is a Readout in Q2 2027.

VXRT catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Indication under review: COVID-19 prevention. Sponsor: Vaxart, Inc. (VXRT). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q2 2027VXRT

Questions

When is oral COVID-19's next FDA decision or readout?

The next tracked catalyst for oral COVID-19 is a Readout in Q2 2027.

What happened at oral COVID-19's most recent FDA decision?

No FDA decision for oral COVID-19 is in our archive yet.

What is oral COVID-19 used for?

In our records oral COVID-19 is under review or in development for COVID-19 prevention.

Who makes oral COVID-19?

Vaxart, Inc. (VXRT).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.